Here are the 8-K filings from Quantinuum Inc. (QNT) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An 8-K covers material events a company has to report between its quarterly reports, so if you follow QNT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full QNT filings page.
Quantinuum Inc. (QNT) reported third-quarter 2026 revenue of $9.1 million, up 233% from $2.7 million a year earlier, and raised its full-year 2026 revenue outlook to $31 million to $34 million from $28 million to $32 million. GAAP gross margin was 33.3%, compared with (43.5%) a year earlier; adjusted gross margin was 74.6%, up 853 basis points.
The quarter also produced a GAAP net loss of $118 million, compared with $52 million, and an adjusted EBITDA loss of $80 million, compared with $45 million. For the nine months ended September 30, revenue was $22.285 million, versus $23.908 million in 2025. Cash and cash equivalents were $1.94 billion as of September 30, 2026. Quantinuum signed its largest cloud agreement, a multi-year extension with a leading global financial institution that includes committed access through Apollo and Nexus. Nexus adoption reached 215 organizations, nearly 20% above the prior quarter, and Helios reached 99.9995% logical fidelity in October. Apollo remains on track for 2029.
Quantinuum Inc. (QNT) entered into a CHIPS Act Other Transaction Agreement with the U.S. Department of Commerce under which a subsidiary may receive up to $100.0 million in federal R&D funding for trapped‑ion quantum computing projects at U.S. sites. The award is structured as multiple payments, with $56.0 million available on or about September 4, 2026, and additional tranches of $32.0 million and $12.0 million tied to defined project milestones.
In connection with the award, Quantinuum issued 2,369,528 shares of Class A common stock to the Department of Commerce and granted registration rights, including a commitment to file and maintain a shelf registration statement covering resales. The award imposes extensive U.S. research‑security, domestic IP control, and domestic‑production requirements, with potential clawback of up to the full disbursed amount and termination rights for material non‑compliance, as well as long‑dated restrictions on transferring award‑funded intellectual property to foreign countries or entities of concern.
Quantinuum Inc. reported strong top-line growth but deep losses for the quarter ended June 30, 2026. Revenue was $8 million, up 279% year-over-year from $2 million, driven by accelerating commercial activity. Despite this, profitability remains challenged: GAAP net loss was $597 million, compared with $57 million a year earlier, and Adjusted EBITDA loss was $68 million versus a $43 million loss in the prior-year quarter. GAAP gross margin improved to (64.4)%, a 27-point improvement, while Adjusted gross margin was 61.7%. The company completed a traditional IPO, raising $1.7 billion in gross proceeds, contributing to $2.1 billion in cash and short-term investments as of June 30, 2026, providing significant funding for its roadmap.
Management issued initial full-year 2026 guidance, expecting revenue of $28–$32 million, indicating continued growth from the current run-rate. Strategically, Quantinuum announced a multi-year partnership with Oracle to deploy its Helios trapped-ion quantum computer as a managed service on Oracle Cloud Infrastructure, supporting hybrid quantum-AI workloads and expanding enterprise and research access to its platform.